An analysis of reports of depression and suicide in patients treated with isotretinoin.
about
The use of isotretinoin in acneDepressogenic effects of medications: a reviewThe neurobiology of retinoic acid in affective disordersPsychodermatology: a guide to understanding common psychocutaneous disordersVitamin A and Retinoids as Mitochondrial ToxicantsWhat is the best approach to reducing birth defects associated with isotretinoin?Acne vulgaris: lasers, light sources and photodynamic therapy--an update 2007.Is the association between acne and mental distress influenced by diet? Results from a cross-sectional population study among 3775 late adolescents in Oslo, Norway.Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgarisThe association between depression and isotretinoin use in acne.Retinoic acid and affective disorders: the evidence for an associationImportant controversies associated with isotretinoin therapy for acne.Does isotretinoin therapy of acne cure or cause depression?Isotretinoin, depression and suicide: a review of the evidence.Accutane (isotretinoin) and psychiatric adverse effects.Decrease in "Hamilton Rating Scale for Depression" Following Isotretinoin Therapy in Acne: An Open-Label Prospective StudyIsotretinoin: controversies, facts, and recommendations.Adverse drug event monitoring at the Food and Drug Administration.General medical with depression drugs associated.Effective monitoring of isotretinoin safety in a pediatric dermatology population: a novel "patient symptom survey" approachTreatment of acne with isotretinoin: recommendations based on Australian experience.The effect of isotretinoin (roaccutane) therapy on depression and quality of life of patients with severe acneToo much of a good thing: retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen.Sadness: diagnosis, evaluation, and treatment.Psychiatric side effects of medications prescribed in internal medicine.Psychological interventions in the management of common skin conditions.The Crucial Involvement of Retinoid X Receptors in DDE Neurotoxicity.Isotretinoin and the controversy of psychiatric adverse effects.Acne: more than skin deep.A Case Report of Isotretinoin-induced Manic Psychosis.Mefloquine use, psychosis, and violence: a retinoid toxicity hypothesisTherapeutic management of psychodermatological disorders.A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgarisPsychodermatological disorders: recognition and treatment.Psychiatric disorders, acne and systemic retinoids: comparison of risks.Acute psychosis induced by isotretinoinIsotretinoin and psychiatric illness in adolescents and young adults.Evaluation of depressive symptoms in acne patients treated with isotretinoin.Isotretinoin has no negative effect on attention, executive function and mood.Acute depression from isotretinoin. Another case.
P2860
Q24630660-953E9C58-24F9-45D1-BCF5-8003E9056567Q24635465-352836FB-70DF-4D0D-9A7B-B1ACA953AC0AQ24654189-B46C27E5-D3C8-4416-B836-94A37C1A92A2Q24678956-1EF13CCE-4234-40BC-B691-30E6A02F5692Q28081121-33E15C2B-17A8-461B-9CFE-578FBE8F994CQ28469074-A1822BF0-865D-4287-AA56-045ABEE66768Q33307189-2E4830EF-4811-4280-9EAF-65DB8F1EC2E3Q33503872-A3F076BE-8EFB-4A4E-81E4-7DF298A58A39Q33683603-FBC59036-C282-4272-9956-3A74DECFD702Q34171393-9FC50202-AF4A-463B-A3C8-2734AC0E2270Q34214697-E6B68B83-4172-4BE4-A330-9075AD8D0B10Q34337328-C15A9129-2769-4F4C-8149-DE8B3C1AEC4DQ34365356-A65332E8-F494-45B5-A8BD-120EC7A2675BQ34395980-87A68086-83CB-4872-B38E-79E91E2D6D95Q34432250-3D2EC1C2-65B3-49FF-8B30-607A06393C85Q34674283-B0B25F7D-1AEA-4880-9F1E-ECA78530B9D4Q34677841-38C1F1F0-8224-49DC-ABE7-2ED6F0AD602AQ34740872-2C079B84-16B3-45A4-BE91-87301FFA8763Q35000814-9798F947-DE43-407D-9D52-62FB265C32E5Q35106854-C92D74B9-F81D-4489-90FD-A8F58EF51D09Q35129458-BA6AF624-C540-4EFE-8B38-84604BD2F5C8Q35182849-49B1A618-5F75-441C-BFDD-F5234FBBB707Q35197077-C5C49AA7-37B1-4F46-ADC0-7905251F4713Q35219833-31863C90-465F-4862-BEF8-6BD2FC23D276Q35236318-C1BC10FA-E135-41E7-89C7-6795DE858692Q35557463-4BB2E9D7-E339-4443-83C3-C5D93030733EQ35840360-1AC5235F-9CB0-4F2C-AAA4-2157E1A5E9EAQ36545101-B8F14A85-C5D6-4495-A938-E52B42BBEC7AQ36557630-775719EC-8433-42E7-B6E3-F8615303EE4FQ36607097-017936AD-36A6-4F7F-A9FE-3467560850E0Q37033564-270ABE7F-0608-4DB9-AB9A-C4CE6F4B6CD5Q37123411-CE345950-C10A-4E86-9FE5-2EE5BD73D4A8Q37287277-491CACA5-121A-444B-9E40-1AFF31144EC5Q37946496-536000CE-5FA0-4EB1-941B-BB46C51E4CDCQ38705270-00874229-8E53-4481-BBED-DFCA93678E61Q42071608-3B57217B-842C-4818-BAAE-470587FE636CQ42166207-37A8E5AC-CCD3-4719-ABA0-FC810D7A83A7Q43287326-D4094751-54B3-4894-9917-F6C0B0395EE0Q44277070-A2A9B7F5-88B9-4832-827B-B8ADE3D4BFFFQ46460449-58513833-16AF-43F3-9BF6-5CBA25EFB9F0
P2860
An analysis of reports of depression and suicide in patients treated with isotretinoin.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@ast
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@en
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@nl
type
label
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@ast
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@en
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@nl
prefLabel
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@ast
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@en
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@nl
P2093
P921
P356
P1476
An analysis of reports of depression and suicide in patients treated with isotretinoin.
@en
P2093
P304
P356
10.1067/MJD.2001.117730
P407
P577
2001-10-01T00:00:00Z